Amaninder Jeet Dhaliwal, MD
Gastroenterology · Florence, SCNPI 1609215599
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (44.2%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Olympus Corporation Of The Americas at 30.6% of the total. 2025 is the largest year on record at $5,395, 2.3 times the $2,330 reported in 2019. Among gastroenterology clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 199 payments — averaging $88.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Olympus Corporation Of The Americas$5K
- Boston Scientific$5K
- Cook Incorporated$2K
- AbbVie$1K
- Cook Medical LLC$722
- Endogastric Solutions, Inc$495
- plus $3K from 25 others
What the payments were for
- Speaking & faculty fees$2,32513%
- Travel & lodging$7,74644%
- Food & beverage$7,46443%
- Education$20%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Olympus Corporation Of The Americas | 32 | $5,358 |
| Boston Scientific | 32 | $4,852 |
| Cook Incorporated | 1 | $2,325 |
| AbbVie | 42 | $1,095 |
| Cook Medical LLC | 10 | $722 |
| Endogastric Solutions, Inc | 11 | $495 |
| Steris Corporation | 5 | $474 |
| Conmed Corporation | 8 | $368 |
| Creo Medical Inc. | 2 | $258 |
| Merit Medical Systems Inc | 3 | $179 |
| Sanofi | 7 | $164 |
| Medtronic | 2 | $162 |
| Ferring Pharmaceuticals Inc. | 6 | $153 |
| 3-d Matrix, Inc. | 1 | $134 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $124 |
| Janssen Scientific Affairs, LLC | 1 | $102 |
| Merck | 5 | $77 |
| Ambu Inc. | 1 | $73 |
| Lucid Diagnostics Inc. | 1 | $72 |
| Ipsen Biopharmaceuticals, Inc | 1 | $42 |
| Olympus America Inc. | 3 | $42 |
| Amgen | 2 | $39 |
| QOL Medical, LLC | 2 | $35 |
| Lilly USA, LLC | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 5 | $33 |
| Bristol Myers Squibb | 2 | $31 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Johnson & Johnson | 1 | $19 |
| Gilead | 1 | $18 |
| Pfizer | 1 | $18 |
| Ardelyx, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ECHOTIP INSIGHT$2,490
- Single Use Electrosurgical Hemostatic Forceps$2,469
- Single Use Electrosurgical Knife KD-655$1,964
- DISPOSABLE DISTAL ATTACHMENT$1,779
- GENERAL - THERAPIES$1,709
- SPYGLASS$1,660
- Olympus EMR & ESD Devices$1,205
- Olympus EUS Devices$1,098
- Olympus Hemostasis Devices$1,098
- Olympus GI Accessories$1,098
- Single Use Repositionable Clip$507
- VISIGLIDE$384
- Olympus$384
- TRUFREEZE$370
- ESOPHYX$367
- CONMED BILIARY$270
- CONMED GENERATORS$270
- CONMED HEMOSTASIS$270
- LumiCoil$208
- Fusion Quattro$157
How this compares
$17,537 in reported general payments places this provider in the 90th percentile of 259 gastroenterology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 43 | $92,673 |
| LinzessLinaclotide | 89 | $84,539 |
| Sucralfate | 37 | $10,736 |
| Dexlansoprazole DrDexlansoprazole | 44 | $8,218 |
| Omeprazole | 303 | $6,024 |
| Pantoprazole Sodium | 526 | $6,023 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 184 | $3,004 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 42 | $2,803 |
| Dicyclomine Hcl | 72 | $2,613 |
| CholestyramineCholestyramine (With Sugar) | 31 | $2,532 |
| Esomeprazole Magnesium | 47 | $2,485 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 147 | $2,469 |
| Ursodiol | 17 | $1,829 |
| Famotidine | 88 | $1,815 |
| Lubiprostone | 14 | $1,519 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon, Linzess | $1,095 | $177,212132 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 259 gastroenterology providers in South Carolina.
Other gastroenterology in Florence
- Davinderbir PannuFlorence$14K
- Erin ForsterCharleston$788K
- Mark DeleggeCharleston$568K
- Nathan ShoresCharleston$217K
- Andre EaddyGreenville$212K
- Alejandro SuarezCharleston$210K
- Veeral OzaGreenville$199K
- Peter CottonCharleston$193K
- Christina BauerGreenville$179K
- Andrew PearsonMyrtle Beach$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.